Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 1221-1223, March 15, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, J. H.
Right arrow Articles by Morimoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, J. H.
Right arrow Articles by Morimoto, K.

Suppression of the Formation of Sister Chromatid Exchanges by Low Concentrations of Ginsenoside Rh2 in Human Blood Lymphocytes1

Jin Hua Zhu, Tatsuya Takeshita, Isao Kitagawa and Kanehisa Morimoto2

Department of Hygiene and Preventive Medicine, Osaka University School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565 [J. H. Z., T. T., K. M.], and Faculty of Pharmaceutical Science, Osaka University, 1-6 Yamada-oka, Suita, Osaka 565, Japan [I. K.]

To assess the antimutagenic potentials of ginsenoside Rh2 (Rh2), its effects on the baseline and mitomycin C-induced sister chromatid exchange (SCE) were examined in human peripheral blood lymphocytes (PBLs). The SCE frequency in PBLs treated with various concentrations of Rh2 for 72 h was decreased in a dose-dependent manner and was significantly lower than the baseline levels at 1.0 x 10-10 M and 1.0 x 10-7 M. The SCE frequency in PBLs treated with both Rh2 and mitomycin C was significantly (P < 0.001) less than that in PBLs treated with only mitomycin C. Cell cycle kinetics, as indicated by the proliferation and mitotic indices, was not significantly affected by Rh2 of various concentrations in the PBLs throughout the present experiments. This is the first report which showed convincingly a reduction of SCE in normal human cells. The mechanism remains to be elucidated in future studies.

1 This work was supported in part by Grants-in-Aid for scientific research from the Ministry of Education, Science, and Culture of Japan and by a Grant-in-Aid for cancer research from the Ministry of Health and Welfare of Japan.

2 To whom requests for reprints should be addressed.

Received 12/16/94. Accepted 2/ 2/95.




This article has been cited by other articles:


Home page
MutagenesisHome page
T.-K. Lee, R. M. Johnke, R. R. Allison, K. F. O'Brien, and L. J. Dobbs Jr
Radioprotective potential of ginseng
Mutagenesis, July 1, 2005; 20(4): 237 - 243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.